UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008205 |
|---|---|
| Receipt number | R000007836 |
| Scientific Title | Phase II study of induction therapy: S-1 and cisplatin with concurrent radiation for patient with stage IIA-IIIA locally advanced non-small cell lung cancer. |
| Date of disclosure of the study information | 2012/06/19 |
| Last modified on | 2021/02/15 20:38:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/06/19 13:22:11 | ||
| 2 | Update | 2013/12/24 11:30:27 | TEL Last name of contact person Last name of contact person Address Address TEL Institutions |
|
| 3 | Update | 2014/12/19 10:31:15 | Recruitment status |
|
| 4 | Update | 2015/06/19 12:02:12 | Publication of results URL related to results and publications Results |
|
| 5 | Update | 2017/12/24 01:26:22 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2018/12/24 11:53:12 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2020/12/01 08:30:52 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
| 8 | Update | 2021/02/15 20:30:03 | Recruitment status Date of IRB |
|
| 9 | Update | 2021/02/15 20:38:36 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
